[Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
Zhao, Qun
[Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer]. [electronic resource] - Zhonghua zhong liu za zhi [Chinese journal of oncology] Oct 2013 - 773-7 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0253-3766
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis--drug effects
Capecitabine
Cell Cycle--drug effects
Chemotherapy, Adjuvant
Deoxycytidine--analogs & derivatives
Disease-Free Survival
Female
Fluorouracil--analogs & derivatives
Follow-Up Studies
Gastrectomy--methods
Humans
Inhibitor of Apoptosis Proteins--metabolism
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Oxaloacetates
Proliferating Cell Nuclear Antigen--metabolism
Proto-Oncogene Proteins p21(ras)--metabolism
Remission Induction
Stomach Neoplasms--drug therapy
Survival Rate
Survivin
Tumor Suppressor Protein p53--metabolism
[Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer]. [electronic resource] - Zhonghua zhong liu za zhi [Chinese journal of oncology] Oct 2013 - 773-7 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0253-3766
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Apoptosis--drug effects
Capecitabine
Cell Cycle--drug effects
Chemotherapy, Adjuvant
Deoxycytidine--analogs & derivatives
Disease-Free Survival
Female
Fluorouracil--analogs & derivatives
Follow-Up Studies
Gastrectomy--methods
Humans
Inhibitor of Apoptosis Proteins--metabolism
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Oxaloacetates
Proliferating Cell Nuclear Antigen--metabolism
Proto-Oncogene Proteins p21(ras)--metabolism
Remission Induction
Stomach Neoplasms--drug therapy
Survival Rate
Survivin
Tumor Suppressor Protein p53--metabolism